Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
MedAdvisor Limited ( (AU:MDR) ) has provided an update.
MedAdvisor Limited has announced the quotation of 389,420 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 20, 2025. This move is part of the company’s strategy to enhance its financial flexibility and potentially strengthen its market position, which could have implications for its stakeholders and operations.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, primarily focusing on providing digital health solutions. The company offers platforms and services that facilitate medication management and improve patient health outcomes.
Average Trading Volume: 804,791
Technical Sentiment Signal: Sell
Current Market Cap: A$54.32M
See more insights into MDR stock on TipRanks’ Stock Analysis page.